Skip to Content

2 (Glipizide Extended-Release 2.5 mg)

Pill with imprint 2 is Yellow, Round and has been identified as Glipizide Extended-Release 2.5 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 2

Glipizide Extended-Release

Imprint
2
Strength
2.5 mg
Color
Yellow
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0335
Inactive Ingredients
acetyltributyl citrate, ammonia, butyl alcohol, FD&C Yellow No. 5, ferrosoferric oxide, hydroxyethyl cellulose (2000 cps at 1%), hypromelloses, isopropyl alcohol, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol, propylene glycol, shellac, silicon dioxide, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "2"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.